Currently holds a position at Albireo Pharma Inc
Position | Company | Period |
---|---|---|
Chief Scientific Officer | Albireo Pharma Inc | Jan. 1, 2019 - |
Chief Operating Officer | Albireo Pharma Inc | Nov. 3, 2016 - Jan. 1, 2019 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-01-23 | 2023-01-23 |
Albireo Pharma Inc
(ALBO)
|
PS Planned sale |
197
-0.4%
43.808,629 USD |
197 -0.4% | 43.80 | 8,629 USD | |
2023-01-20 | 2023-01-19 |
Albireo Pharma Inc
(ALBO)
|
PS Planned sale |
3,088
-5.3%
43.80135,254 USD |
3,088 -5.3% | 43.80 | 135,254 USD | |
2022-10-25 | 2022-10-24 |
Albireo Pharma Inc
(ALBO)
|
PS Planned sale |
202
-0.3%
19.583,954 USD |
202 -0.3% | 19.58 | 3,954 USD | |
2022-07-25 | 2022-07-22 |
Albireo Pharma Inc
(ALBO)
|
PS Planned sale |
205
-0.4%
24.685,058 USD |
205 -0.4% | 24.68 | 5,058 USD | |
2022-04-25 | 2022-04-22 |
Albireo Pharma Inc
(ALBO)
|
PS Planned sale |
200
-0.3%
32.926,585 USD |
200 -0.3% | 32.92 | 6,585 USD | |
2022-01-25 | 2022-01-24 |
Albireo Pharma Inc
(ALBO)
|
PS Planned sale |
808
-1.4%
24.8820,105 USD |
808 -1.4% | 24.88 | 20,105 USD | |
2021-03-03 | 2021-03-03 |
Albireo Pharma Inc
(ALBO)
|
S Sale |
400
-1.1%
36.2014,481 USD |
400 -1.1% | 36.20 | 14,481 USD | |
2021-03-03 | 2021-03-02 |
Albireo Pharma Inc
(ALBO)
|
S Sale |
2,807
-6.9%
37.15104,281 USD |
2,807 -6.9% | 37.15 | 104,281 USD | |
2021-03-03 | 2021-03-02 |
Albireo Pharma Inc
(ALBO)
|
S Sale |
612
-1.5%
36.5422,365 USD |
612 -1.5% | 36.54 | 22,365 USD | |
2021-03-03 | 2021-03-02 |
Albireo Pharma Inc
(ALBO)
|
S Sale |
12,351
-23.0%
36.07445,561 USD |
12,351 -23.0% | 36.07 | 445,561 USD | |
2021-03-03 | 2021-03-01 |
Albireo Pharma Inc
(ALBO)
|
S Sale |
15,300
-22.2%
37.45572,996 USD |
15,300 -22.2% | 37.45 | 572,996 USD | |
2020-09-10 | 2020-09-08 |
Albireo Pharma Inc
(ALBO)
|
PS Planned sale |
10,000
-29.2%
45.55455,500 USD |
10,000 -29.2% | 45.55 | 455,500 USD |